Cargando…
Cochlear dysfunction and microvascular complications in patients with type 1 diabetes mellitus
Sensorineural hearing impairment has been associated with DM, and it is probably linked to the same pathophysiological mechanisms as well-established in microvascular diabetes complications. The study of otoacoustic emissions (OAEs) is useful to identify subclinical cochlear dysfunction. Therefore,...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230237/ https://www.ncbi.nlm.nih.gov/pubmed/30455746 http://dx.doi.org/10.1186/s13098-018-0380-z |
_version_ | 1783370043255422976 |
---|---|
author | Felício, João Soares de Souza d’Albuquerque Silva, Lilian Martins, Carlliane Lima e Lins Pinto Neto, João Felício Abrahão de Lemos, Manuela Nascimento de Souza Resende, Fabrício da Silva, Wanderson Maia de Alcântara, Angélica Leite de Oliveira, Maria Clara Neres Iunes de Souza Neto, Norberto Jorge Kzan de Franco, Isabela Imbelloni Farias Zahalan, Nathalie Abdallah Janaú, Luísa Correa de Souza, Ana Carolina Contente Braga Santos, Flavia Marques de Queiroz, Natércia Neves Marques Mourão, Neyla Arroyo Lara dos Santos, Márcia Costa Felício, Karem Miléo de Melo, Franciane Trindade Cunha |
author_facet | Felício, João Soares de Souza d’Albuquerque Silva, Lilian Martins, Carlliane Lima e Lins Pinto Neto, João Felício Abrahão de Lemos, Manuela Nascimento de Souza Resende, Fabrício da Silva, Wanderson Maia de Alcântara, Angélica Leite de Oliveira, Maria Clara Neres Iunes de Souza Neto, Norberto Jorge Kzan de Franco, Isabela Imbelloni Farias Zahalan, Nathalie Abdallah Janaú, Luísa Correa de Souza, Ana Carolina Contente Braga Santos, Flavia Marques de Queiroz, Natércia Neves Marques Mourão, Neyla Arroyo Lara dos Santos, Márcia Costa Felício, Karem Miléo de Melo, Franciane Trindade Cunha |
author_sort | Felício, João Soares |
collection | PubMed |
description | Sensorineural hearing impairment has been associated with DM, and it is probably linked to the same pathophysiological mechanisms as well-established in microvascular diabetes complications. The study of otoacoustic emissions (OAEs) is useful to identify subclinical cochlear dysfunction. Therefore, the aim of this study was to evaluate the association between abnormal OAEs responses, diabetic kidney disease (DKD) and diabetic cardiac autonomic neuropathy (CAN). We performed a cross-sectional study with 37 type 1 DM patients without auditory symptoms, submitted to the study of Distortion Product Otoacoustic Emissions (DPOAEs) and screened for DKD and CAN. The otoacoustic emissions responses were considered abnormal in 27/37 (73%) patients. A correlation was found between abnormal OAEs responses and presence of DKD (r = 0.36, p < 0.05), and 14/16 (88%) patients with a lower amplitude of OAEs in 8 kHz frequency band presented DKD. Abnormal OAEs responses in the 6 kHz frequency band were correlated with the presence (r = 0.41, p = 0.01) and severity of CAN (r = 0.44, p < 0.001). Additionally, 7/9 (78%) patients with abnormal OAE responses in this frequency also presented abnormal CAN scores. Our results suggest that abnormal otoacoustic emissions responses in high frequency bands are associated with diabetes microvascular complications and could be a risk marker for DKD and CAN, presenting low sensitivity and high specificity. Therefore, assuming that hearing impairment is a pre-clinical stage of hearing loss, performing distortion product otoacoustic emissions in T1DM patients with microvascular complications could be useful to identify those who would be benefit with regular audiologic follow up and tighter diabetes control. |
format | Online Article Text |
id | pubmed-6230237 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62302372018-11-19 Cochlear dysfunction and microvascular complications in patients with type 1 diabetes mellitus Felício, João Soares de Souza d’Albuquerque Silva, Lilian Martins, Carlliane Lima e Lins Pinto Neto, João Felício Abrahão de Lemos, Manuela Nascimento de Souza Resende, Fabrício da Silva, Wanderson Maia de Alcântara, Angélica Leite de Oliveira, Maria Clara Neres Iunes de Souza Neto, Norberto Jorge Kzan de Franco, Isabela Imbelloni Farias Zahalan, Nathalie Abdallah Janaú, Luísa Correa de Souza, Ana Carolina Contente Braga Santos, Flavia Marques de Queiroz, Natércia Neves Marques Mourão, Neyla Arroyo Lara dos Santos, Márcia Costa Felício, Karem Miléo de Melo, Franciane Trindade Cunha Diabetol Metab Syndr Research Sensorineural hearing impairment has been associated with DM, and it is probably linked to the same pathophysiological mechanisms as well-established in microvascular diabetes complications. The study of otoacoustic emissions (OAEs) is useful to identify subclinical cochlear dysfunction. Therefore, the aim of this study was to evaluate the association between abnormal OAEs responses, diabetic kidney disease (DKD) and diabetic cardiac autonomic neuropathy (CAN). We performed a cross-sectional study with 37 type 1 DM patients without auditory symptoms, submitted to the study of Distortion Product Otoacoustic Emissions (DPOAEs) and screened for DKD and CAN. The otoacoustic emissions responses were considered abnormal in 27/37 (73%) patients. A correlation was found between abnormal OAEs responses and presence of DKD (r = 0.36, p < 0.05), and 14/16 (88%) patients with a lower amplitude of OAEs in 8 kHz frequency band presented DKD. Abnormal OAEs responses in the 6 kHz frequency band were correlated with the presence (r = 0.41, p = 0.01) and severity of CAN (r = 0.44, p < 0.001). Additionally, 7/9 (78%) patients with abnormal OAE responses in this frequency also presented abnormal CAN scores. Our results suggest that abnormal otoacoustic emissions responses in high frequency bands are associated with diabetes microvascular complications and could be a risk marker for DKD and CAN, presenting low sensitivity and high specificity. Therefore, assuming that hearing impairment is a pre-clinical stage of hearing loss, performing distortion product otoacoustic emissions in T1DM patients with microvascular complications could be useful to identify those who would be benefit with regular audiologic follow up and tighter diabetes control. BioMed Central 2018-11-09 /pmc/articles/PMC6230237/ /pubmed/30455746 http://dx.doi.org/10.1186/s13098-018-0380-z Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Felício, João Soares de Souza d’Albuquerque Silva, Lilian Martins, Carlliane Lima e Lins Pinto Neto, João Felício Abrahão de Lemos, Manuela Nascimento de Souza Resende, Fabrício da Silva, Wanderson Maia de Alcântara, Angélica Leite de Oliveira, Maria Clara Neres Iunes de Souza Neto, Norberto Jorge Kzan de Franco, Isabela Imbelloni Farias Zahalan, Nathalie Abdallah Janaú, Luísa Correa de Souza, Ana Carolina Contente Braga Santos, Flavia Marques de Queiroz, Natércia Neves Marques Mourão, Neyla Arroyo Lara dos Santos, Márcia Costa Felício, Karem Miléo de Melo, Franciane Trindade Cunha Cochlear dysfunction and microvascular complications in patients with type 1 diabetes mellitus |
title | Cochlear dysfunction and microvascular complications in patients with type 1 diabetes mellitus |
title_full | Cochlear dysfunction and microvascular complications in patients with type 1 diabetes mellitus |
title_fullStr | Cochlear dysfunction and microvascular complications in patients with type 1 diabetes mellitus |
title_full_unstemmed | Cochlear dysfunction and microvascular complications in patients with type 1 diabetes mellitus |
title_short | Cochlear dysfunction and microvascular complications in patients with type 1 diabetes mellitus |
title_sort | cochlear dysfunction and microvascular complications in patients with type 1 diabetes mellitus |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230237/ https://www.ncbi.nlm.nih.gov/pubmed/30455746 http://dx.doi.org/10.1186/s13098-018-0380-z |
work_keys_str_mv | AT feliciojoaosoares cochleardysfunctionandmicrovascularcomplicationsinpatientswithtype1diabetesmellitus AT desouzadalbuquerquesilvalilian cochleardysfunctionandmicrovascularcomplicationsinpatientswithtype1diabetesmellitus AT martinscarllianelimaelinspinto cochleardysfunctionandmicrovascularcomplicationsinpatientswithtype1diabetesmellitus AT netojoaofelicioabrahao cochleardysfunctionandmicrovascularcomplicationsinpatientswithtype1diabetesmellitus AT delemosmanuelanascimento cochleardysfunctionandmicrovascularcomplicationsinpatientswithtype1diabetesmellitus AT desouzaresendefabricio cochleardysfunctionandmicrovascularcomplicationsinpatientswithtype1diabetesmellitus AT dasilvawandersonmaia cochleardysfunctionandmicrovascularcomplicationsinpatientswithtype1diabetesmellitus AT dealcantaraangelicaleite cochleardysfunctionandmicrovascularcomplicationsinpatientswithtype1diabetesmellitus AT deoliveiramariaclaraneresiunes cochleardysfunctionandmicrovascularcomplicationsinpatientswithtype1diabetesmellitus AT desouzanetonorbertojorgekzan cochleardysfunctionandmicrovascularcomplicationsinpatientswithtype1diabetesmellitus AT defrancoisabelaimbellonifarias cochleardysfunctionandmicrovascularcomplicationsinpatientswithtype1diabetesmellitus AT zahalannathalieabdallah cochleardysfunctionandmicrovascularcomplicationsinpatientswithtype1diabetesmellitus AT janauluisacorrea cochleardysfunctionandmicrovascularcomplicationsinpatientswithtype1diabetesmellitus AT desouzaanacarolinacontentebraga cochleardysfunctionandmicrovascularcomplicationsinpatientswithtype1diabetesmellitus AT santosflaviamarques cochleardysfunctionandmicrovascularcomplicationsinpatientswithtype1diabetesmellitus AT dequeiroznatercianevesmarques cochleardysfunctionandmicrovascularcomplicationsinpatientswithtype1diabetesmellitus AT mouraoneylaarroyolara cochleardysfunctionandmicrovascularcomplicationsinpatientswithtype1diabetesmellitus AT dossantosmarciacosta cochleardysfunctionandmicrovascularcomplicationsinpatientswithtype1diabetesmellitus AT feliciokaremmileo cochleardysfunctionandmicrovascularcomplicationsinpatientswithtype1diabetesmellitus AT demelofrancianetrindadecunha cochleardysfunctionandmicrovascularcomplicationsinpatientswithtype1diabetesmellitus |